Advik Laboratories share news and announcements
BSE: 531686Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 19 Oct 2026. Previous close ₹2.08.
- Under BSE's graded surveillance, stage IV, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹3.98 Cr5,167th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 28 May 2026
- 58.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- −180.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- −14.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 28 May 2026
- 109.84
- Volume, BSEVolume. Shares traded on the last trading day.
- 300
Advik Laboratories share news and announcements
601 announcements, routine notices left out, newest first. Page 2 of 13.
Aug 2025
4 Aug · Board meeting
Meeting on 12 Aug 2025: quarterly results
Jul 2025
11 Jul · Submission Of Investor Complaint For The Quarter Ended 30.06.2025
May 2025
28 May · Regulation 23(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015, Please Find Enclosed Herewith Disclosure Under 'Related Party Transaction' For The Half Year Ended 31St March, 2025
19 May · Board meeting
Meeting on 28 May 2025: quarterly results and audited results
Apr 2025
30 Apr · Confirmation On Non Applicability Of The Criteria Specified Under SEBI Circular No. SEBI/HO/DDHS CIR/P/2018/144 Dated 26Th November, 2018Read With Circular No. LIST/COMP/05/2019-20 Dated April 11, 2019
16 Apr · Pursuant To Regulation 13(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, Please Find Herein Below The Statement Of Investor Complaints For The Quarter Ended 31Stmarch, 2025 For Your Kind Perusal
Mar 2025
13 Mar · Outcome Of Independent Directors Meeting
8 Mar · Notice Of Separate Meeting Of Independent Directors Of The Company
Feb 2025
12 Feb · Results
12 Feb · Results
Jan 2025
27 Jan · Board meeting
Meeting on 12 Feb 2025: quarterly results
Nov 2024
14 Nov · Disclosure Of Related Party Transactions For The Half Year Ended September 30, 2024 Pursuant To Regulation 23(9) Of The SEBI (LODR), Regulation, 2015
Oct 2024
30 Oct · Board meeting
Meeting on 14 Nov 2024: quarterly results
Sep 2024
30 Sep · Meeting
29 Sep · Meeting
28 Sep · Meeting
Aug 2024
28 Aug · Board meeting
Meeting on 2 Sep 2024: annual general meeting
Jul 2024
30 Jul · Board meeting
Meeting on 13 Aug 2024: quarterly results
Jun 2024
20 Jun · Certificate Of Non-Disqualification Of Directors Under Regulation 34(3) And Schedule V Para C Clause (10)(I) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March, 2024
May 2024
30 May · Disclosure Of Related Party Transactions For The Half Year Ended March 31, 2024 Pursuant To Regulation 23(9) Of The SEBI (LODR), Regulation, 2015
30 May · Management
14 May · Board meeting
Meeting on 30 May 2024: audited results10 May · Legal